Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBEENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBEENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBENUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.93 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.93 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.93 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.93 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.31.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.31.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.31.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.31.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.5.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.5.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DN.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DN.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BW.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BW.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used